Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
about
CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatment.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.
P2860
Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Association of CYP2C19*2 and a ...... Asian breast cancer patients.
@en
type
label
Association of CYP2C19*2 and a ...... Asian breast cancer patients.
@en
prefLabel
Association of CYP2C19*2 and a ...... Asian breast cancer patients.
@en
P2093
P2860
P356
P1476
Association of CYP2C19*2 and a ...... d Asian breast cancer patients
@en
P2093
Balram Chowbay
Joanne Siok Liu Lim
Matthias Schwab
Nan Soon Wong
Natalia Sutiman
Onkar Singh
Peter Cher Siang Ang
Raymond Chee Hui Ng
Rebecca Dent
Thomas E Muerdter
P2860
P304
P356
10.1111/BCP.12886
P407
P50
P577
2016-03-08T00:00:00Z